Department of Medicine and Interdepartmental Division of Critical Care Medicine, the Keenan Research Centre at the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Crit Care Med. 2012 Jun;40(6):1896-907. doi: 10.1097/CCM.0b013e31824e1370.
We hypothesized that resveratrol administration would reverse sepsis-dependent downregulation of peroxisome proliferator activated receptor-γ coactivator 1α, preserve mitochondrial integrity, and rescue animals from sepsis-induced myocardial failure.
Teaching hospital research laboratory.
Cecal ligation and puncture in mice was performed to induce sepsis. Mice that underwent cecal ligation and puncture were randomly assigned to receive resveratrol (30 mg/kg or 60 mg/kg) or vehicle 1 mL sodium chloride 0.9% subcutaneously in the scruff of the neck directly after surgery and at 16, 24, and 40 hrs, respectively.
Forty-eight hrs after cecal ligation and puncture, cardiac performance was established using echocardiography. Mitochondrial integrity was evaluated with electron microscopy, and changes in gene expression were evaluated with microarray analysis. Survival at 48 hrs was just under 50% and comparable between groups. Myocardial contractile function significantly improved after resveratrol treatment. Resveratrol-treated mice developed focal areas of edema, whereas vehicle-treated mice developed significant, diffuse myocardial edema. Electron microscopy revealed widespread swollen mitochondria with ruptured outer membranes, autophagosomes, and vacuolation of the internal compartment, which were significantly attenuated in resveratrol-treated animals. Resveratrol treatment significantly increased cardiac expression of peroxisome proliferator-activated receptor-γ coactivator 1a. Microarray analysis revealed that resveratrol treatment resulted in upregulation of the peroxisome proliferator-activated receptor-γ coactivator gene set containing genes known to be regulated by this transcriptional coactivator. Our data strongly suggest that administration of resveratrol modulates bioenergy metabolism, substrate utilization, oxidative stress, and detoxification pathways associated with both mitochondrial and cardiac pathological conditions, but does not alter mortality from sepsis.
The salutary effects of resveratrol on cecal ligation and puncture-induced myocardial dysfunction are associated with increased peroxisome proliferator-activated receptor-γ coactivator 1a abundance and function. Preservation of myocardial energy production capacity, prevention of secondary injury, mitigation of inflammation, and reversal of sepsis-induced myocardial remodeling are likely to underlie its beneficial effects. This however, does not result in improved survival.
我们假设白藜芦醇的使用可以逆转脓毒症导致的过氧化物酶体增殖物激活受体γ共激活因子 1α 的下调,维持线粒体的完整性,并使动物免受脓毒症引起的心肌衰竭。
教学医院研究实验室。
对小鼠进行盲肠结扎和穿刺以诱导脓毒症。接受盲肠结扎和穿刺的小鼠被随机分配接受白藜芦醇(30mg/kg 或 60mg/kg)或皮下颈部 1ml 生理盐水 0.9%,分别在手术后立即以及 16、24 和 40 小时后给予。
盲肠结扎和穿刺后 48 小时,通过超声心动图评估心功能。使用电子显微镜评估线粒体的完整性,并通过微阵列分析评估基因表达的变化。48 小时的存活率接近 50%,各组之间无差异。白藜芦醇治疗后心肌收缩功能明显改善。白藜芦醇治疗的小鼠出现局灶性水肿,而载体治疗的小鼠出现明显弥漫性心肌水肿。电子显微镜显示广泛肿胀的线粒体,外膜破裂,自噬体,以及内部隔室的空泡化,在白藜芦醇治疗的动物中明显减轻。白藜芦醇治疗显著增加了心脏过氧化物酶体增殖物激活受体-γ共激活因子 1a 的表达。微阵列分析显示,白藜芦醇治疗导致过氧化物酶体增殖物激活受体-γ共激活因子基因集的上调,该基因集包含已知受该转录共激活因子调节的基因。我们的数据强烈表明,白藜芦醇的给药调节与线粒体和心脏病理状况相关的生物能量代谢、底物利用、氧化应激和解毒途径,但不能改变脓毒症的死亡率。
白藜芦醇对盲肠结扎和穿刺诱导的心肌功能障碍的有益作用与过氧化物酶体增殖物激活受体-γ共激活因子 1a 的丰度和功能增加有关。维持心肌能量产生能力、防止二次损伤、减轻炎症以及逆转脓毒症引起的心肌重构可能是其有益作用的基础。然而,这并没有导致存活率的提高。